Evidence map›Paper›PMID 38321901›Full record

ReviewRecent patents on nanotechnology2025

Role of Nanoformulations in the Treatment of Lung Cancer.

Parijat Pandey, Gunjan Nautiyal, Deepika Purohit, Sneh Lata, Virender Kumar, Manish Makhija, Deeksha Manchanda, Neha Minocha, Sunil Kumar, Deepak Kaushik

Abstract readReview
PubMed Publisher
In one paragraph

Review in Recent patents on nanotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Parijat PandeyDepartment of Pharmaceutical Sciences, Gurugram University, Gurugram, 122018, Haryana, India.ORCID 0000-0003-2298-3645
Gunjan NautiyalDepartment of Pharmaceutical Sciences, Gurugram University, Gurugram, 122018, Haryana, India.ORCID 0009-0009-8754-5989
Deepika PurohitDepartment of Pharmaceutical Sciences, Indira Gandhi University, Meerpur, Rewari, 123401, Haryana, India.ORCID 0000-0001-6599-4737
Sneh LataDepartment of Pharmaceutical Sciences, Indira Gandhi University, Meerpur, Rewari, 123401, Haryana, India.
Virender KumarCollege of Pharmacy, Pandit Bhagwat Dayal Sharma University of Health Sciences, Rohtak, 124001, Haryana, India.ORCID 0000-0002-4699-1781
Manish MakhijaDepartment of Pharmaceutical Sciences, Indira Gandhi University, Meerpur, Rewari, 123401, Haryana, India.ORCID 0000-0003-2266-226X
Deeksha ManchandaDepartment of Pharmaceutical Sciences, Indira Gandhi University, Meerpur, Rewari, 123401, Haryana, India.ORCID 0000-0002-2264-6609
Neha MinochaAmity Institute of Pharmacy, Amity University, Gurugram, 122413, Haryana, India.ORCID 0000-0002-0870-4972
Sunil KumarDepartment of Pharmaceutical Sciences, Indira Gandhi University, Meerpur, Rewari, 123401, Haryana, India.ORCID 0000-0002-5905-3372
Deepak KaushikDepartment of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, Haryana, India.ORCID 0000-0002-3286-196X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is the second deadliest disease in the world. A major portion of deaths related to cancer are due to lung cancer in both males and females. Interestingly, unbelievable advances have occurred in recent years through the use of nanotechnology and development in both the diagnosis and treatment of lung cancer. Due to their

Indexed as

Antineoplastic AgentsLung NeoplasmsNanoparticlesAnimalsHumansNanotechnologyPatents as TopicAntineoplastic Agentsclinical trialsdiagnosisestrogen.lung cancernanoformulationsNanotechnology

Identifiers

PMID38321901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.